Try our beta test site
6 studies found for:    syn115
Show Display Options
Rank Status Study
1 Completed Study to Evaluate SYN115 in Parkinson's Disease
Condition: Parkinson's Disease
Interventions: Drug: Placebo;   Drug: Tozadenant
2 Completed Safety and Efficacy Study of SYN115 in Parkinson's Patients Using Levodopa to Treat End of Dose Wearing Off
Condition: Parkinson's Disease
Interventions: Drug: Tozadenant (SYN115) 60 mg BID;   Drug: Placebo;   Drug: Levodopa (L-dopa);   Drug: Tozadenant (SYN115) 120 mg BID;   Drug: Tozadenant (SYN115) 180 mg BID;   Drug: Tozadenant (SYN115) 240 mg BID
3 Completed An fMRI Study of SYN115 in Cocaine Dependent Subjects
Condition: Cocaine Dependence
Interventions: Drug: SYN115;   Drug: PLACEBO
4 Not yet recruiting A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
Condition: Idiopathic Parkinson Disease
Intervention: Drug: Tozadenant
5 Completed Study to Evaluate the Absorption, Distribution, Break Down and Elimination and the Safety of 14C-Labeled Tozadenant
Condition: N/A, as Healthy Volunteers
Interventions: Drug: tozadenant tablet;   Drug: C14-tozadenant capsule
6 Recruiting Safety and Efficacy Study of Tozadenant to Treat End of Dose Wearing Off in Parkinson's Patients Using Levodopa
Condition: Idiopathic Parkinson's Disease
Interventions: Drug: tozadenant;   Drug: placebo

Study has passed its completion date and status has not been verified in more than two years.